Clinical Trials Directory

Trials / Completed

CompletedNCT06112223

Preemptive Oral Gabapentin and Tramadol on Postoperative Pain After Knee Arthroscopy

Preemptive Oral Gabapentin Versus Tramadol on Postoperative Pain After Knee Arthroscopy Done Under Spinal Anesthesia: A Prospective Randomized Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
50 (actual)
Sponsor
Tanta University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The aim of this study to evaluate the effect of preemptive oral gabapentin versus tramadol on postoperative pain after knee arthroscopy under spinal anesthesia.

Detailed description

Orthopedic surgeries are frequently associated with moderate-to-severe postoperative pain that can decrease mobility in the immediate postoperative period, interfere with postoperative rehabilitation, and delay hospital discharge. Pain may also become chronic. Spinal anesthesia is the most popular anesthesia technique worldwide in orthopedic lower limb surgeries. However, its relatively short duration of action may limit the excellent postoperative analgesic effect. Thus, many adjuvants had been used to improve postoperative analgesia and decrease consumption of postoperative analgesics. Gabapentin is a gamma aminobutyric acid analogue that is known as an anticonvulsant drug. This drug is tolerated well and has known effects on pain and anxiety. Tramadol, a commonly used postoperative analgesic, is a synthetic centrally acting opioid analgesic. The various actions include inhibition of noradrenaline and serotonin reuptake, and also inhibition of M1 and M3 muscarinic receptors

Conditions

Interventions

TypeNameDescription
DRUGGabapentinPatients will receive oral gabapentin 600 mg 1 hour before the surgery.
DRUGTramadolPatients will receive oral tramadol 100 mg 1 hour before the surgery.

Timeline

Start date
2023-04-01
Primary completion
2023-09-01
Completion
2023-09-01
First posted
2023-11-01
Last updated
2024-10-02

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06112223. Inclusion in this directory is not an endorsement.